Tissue plasminogen activator does not benefit most eligible patients with stroke

Arch Neurol. 2009 Apr;66(4):540-1; author reply 541. doi: 10.1001/archneurol.2009.43.
No abstract available

Publication types

  • Letter

MeSH terms

  • Controlled Clinical Trials as Topic
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Intracranial Embolism / drug therapy*
  • Neurologic Examination / drug effects
  • Thrombolytic Therapy*
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator